Literature DB >> 30811321

Adherence to Recommended Inpatient Hepatic Encephalopathy Workup.

Dennis Kumral1, Rehan Qayyum2, Susan Roseff3, Richard K Sterling1, Mohammad S Siddiqui1.   

Abstract

Hepatic encephalopathy (HE) is characterized by altered sensorium and is the most common indication for hospitalization among patients with cirrhosis. Liver societal guidelines for inpatient HE revolve around identification of potential precipitants. In this retrospective study, we aimed to determine adherence to societal guidelines for evaluation of HE in 78 inpatients. The adherence rate to societal recommended guidelines for workup of HE was low, with only 17 (22%) patients having complete diagnostic workup within 24 hours of admission. Notably, 23 (30%) patients were not subjected to blood culture analysis, 16 (21%) were missing urinalysis, and 15 (20%) were missing chest radiograph. In patients with ascites (N = 34), 26 (77%) did not have a diagnostic paracentes is to exclude spontaneous bacterial peritonitis. In contrast, serum ammonia determination, a laboratory test not endorsed by societal guidelines for workup of HE, was ordered in 74 (95%) patients. These findings underscore the limited adherence to societal guidelines in hospitalized patients with HE.

Entities:  

Year:  2019        PMID: 30811321     DOI: 10.12788/jhm.3152

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  7 in total

Review 1.  Cause for Confusion: Noncirrhotic Hyperammonemic Encephalopathy.

Authors:  Avash Kalra; J P Norvell
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-06-30

2.  Adherence to quality indicators and hospital outcomes for patients with decompensated cirrhosis: An observational study.

Authors:  Krista R Wooller; Dominique Yelle; Stacy Fisher; Ian Carrigan; Erin Kelly
Journal:  Can Liver J       Date:  2020-11-17

3.  Serum ammonia use: unnecessary, frequent and costly.

Authors:  Elizabeth Aby; Andrew P J Olson; Nicholas Lim
Journal:  Frontline Gastroenterol       Date:  2021-08-18

Review 4.  Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends.

Authors:  Sasha Deutsch-Link; Andrew M Moon; Yue Jiang; A Sidney Barritt; Elliot B Tapper
Journal:  Clin Ther       Date:  2022-02-04       Impact factor: 3.637

5.  A Prospective, Blinded Assessment of Ammonia Testing Demonstrates Low Utility Among Front-Line Clinicians.

Authors:  Juan J Gonzalez; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2021-01-13       Impact factor: 11.382

Review 6.  The Future of Quality Improvement for Cirrhosis.

Authors:  Elliot B Tapper; Neehar D Parikh
Journal:  Liver Transpl       Date:  2021-07-31       Impact factor: 6.112

Review 7.  Inadequate practices for hepatic encephalopathy management in the inpatient setting.

Authors:  Jawaid Shaw; Lisa Beyers; Jasmohan S Bajaj
Journal:  J Hosp Med       Date:  2022-08       Impact factor: 2.899

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.